{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T12:28:36Z","timestamp":1768739316141,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,28]],"date-time":"2016-10-28T00:00:00Z","timestamp":1477612800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12872-016-0382-4","type":"journal-article","created":{"date-parts":[[2016,10,28]],"date-time":"2016-10-28T00:09:45Z","timestamp":1477613385000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Myocardial lipid content in Fabry disease: a combined 1H-MR spectroscopy and MR imaging study at 3 Tesla"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9909-1592","authenticated-orcid":false,"given":"B.","family":"Petritsch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"K\u00f6stler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Horn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Gassenmaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. S.","family":"Kunz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Weidemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Wanner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. A.","family":"Bley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Beer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,28]]},"reference":[{"key":"382_CR1","volume-title":"The Metabolic & Molecular Bases of Inherited Disease","author":"R Desnick","year":"2001","unstructured":"Desnick R, Ioannou Y, Eng C. In: Scriver C, Beude A, Valle D, Sly W, editors. The Metabolic & Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill; 2001.","edition":"8"},{"issue":"Suppl 2","key":"382_CR2","first-page":"172","volume":"2","author":"RJ Desnick","year":"2006","unstructured":"Desnick RJ, Banikazemi M. Fabry disease: clinical spectrum and evidence-based enzyme replacement therapy. Nephrol Ther. 2006;2 Suppl 2:172\u201385.","journal-title":"Nephrol Ther"},{"key":"382_CR3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.281.3.249","volume":"281","author":"PJ Meikle","year":"1999","unstructured":"Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. JAMA. 1999;281:249\u201354.","journal-title":"JAMA"},{"key":"382_CR4","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.jcmg.2011.01.020","volume":"4","author":"M Niemann","year":"2011","unstructured":"Niemann M, Herrmann S, Hu K, Breunig F, Strotmann J, Beer M, et al. Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment. JACC Cardiovasc Imaging. 2011;4:592\u2013601.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"Suppl 2","key":"382_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1023\/A:1012447102358","volume":"24","author":"KD MacDermot","year":"2001","unstructured":"MacDermot KD, Holmes A, Miners AH. Natural history of Fabry disease in affected males and obligate carrier females. J Inherit Metab Dis. 2001;24 Suppl 2:13\u20134. discussion 11\u20132.","journal-title":"J Inherit Metab Dis"},{"key":"382_CR6","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.amjcard.2005.11.087","volume":"97","author":"M Beer","year":"2006","unstructured":"Beer M, Weidemann F, Breunig F, Knoll A, Koeppe S, Machann W, et al. Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry\u2019s cardiomyopathy. Am J Cardiol. 2006;97:1515\u20138.","journal-title":"Am J Cardiol"},{"key":"382_CR7","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1016\/j.ehj.2003.09.017","volume":"24","author":"JCC Moon","year":"2003","unstructured":"Moon JCC, Sachdev B, Elkington AG, McKenna WJ, Mehta A, Pennell DJ, et al. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J. 2003;24:2151\u20135.","journal-title":"Eur Heart J"},{"key":"382_CR8","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.2459\/01.JCM.0000296538.82763.f0","volume":"8","author":"C Silva","year":"2007","unstructured":"Silva C, Moon JC, Elkington AG, John AS, Mohiaddin RH, Pennell DJ. Myocardial late gadolinium enhancement in specific cardiomyopathies by cardiovascular magnetic resonance: a preliminary experience. J Cardiovasc Med (Hagerstown). 2007;8:1076\u20139.","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"382_CR9","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1750-1172-8-116","volume":"8","author":"F Weidemann","year":"2013","unstructured":"Weidemann F, Sanchez-Ni\u00f1o MD, Politei J, Oliveira J-P, Wanner C, Warnock DG, et al. Fibrosis: a key feature of Fabry disease with potential therapeutic implications. Orphanet J Rare Dis. 2013;8:116.","journal-title":"Orphanet J Rare Dis"},{"key":"382_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ymgme.2004.01.011","volume":"82","author":"T L\u00fccke","year":"2004","unstructured":"L\u00fccke T, H\u00f6ppner W, Schmidt E, Illsinger S, Das AM. Fabry disease: reduced activities of respiratory chain enzymes with decreased levels of energy-rich phosphates in fibroblasts. Mol Genet Metab. 2004;82:93\u20137.","journal-title":"Mol Genet Metab"},{"key":"382_CR11","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10545-014-9677-8","volume":"37","author":"SM Rombach","year":"2014","unstructured":"Rombach SM, Smid BE, Linthorst GE, Dijkgraaf MGW, Hollak CEM. Natural course of Fabry disease and the effectiveness of enzyme replacement therapy: a systematic review and meta-analysis: Effectiveness of ERT in different disease stages. J Inherit Metab Dis. 2014;37:341\u201352.","journal-title":"J Inherit Metab Dis"},{"key":"382_CR12","unstructured":"Riccio E, Capuano I, Visciano B, Marchetiello C, Petrillo F, Pisani A. Enzyme replacement therapy in patients with Fabry disease: state of the art and review of the literature. G Ital Nefrol. 2013;30."},{"key":"382_CR13","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1161\/CIRCIMAGING.113.000482","volume":"6","author":"RB Thompson","year":"2013","unstructured":"Thompson RB, Chow K, Khan A, Chan A, Shanks M, Paterson I, et al. T1 mapping with cardiovascular MRI is highly sensitive for Fabry disease independent of hypertrophy and sex. Circ Cardiovasc Imaging. 2013;6:637\u201345.","journal-title":"Circ Cardiovasc Imaging"},{"key":"382_CR14","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1161\/CIRCIMAGING.112.000070","volume":"6","author":"DM Sado","year":"2013","unstructured":"Sado DM, White SK, Piechnik SK, Banypersad SM, Treibel T, Captur G, et al. Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping. Circ Cardiovasc Imaging. 2013;6:392\u20138.","journal-title":"Circ Cardiovasc Imaging"},{"key":"382_CR15","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jjcc.2007.12.001","volume":"51","author":"T Takenaka","year":"2008","unstructured":"Takenaka T, Teraguchi H, Yoshida A, Taguchi S, Ninomiya K, Umekita Y, et al. Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study. J Cardiol. 2008;51:50\u20139.","journal-title":"J Cardiol"},{"key":"382_CR16","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1681\/ASN.2006080816","volume":"18","author":"DP Germain","year":"2007","unstructured":"Germain DP, Waldek S, Banikazemi M, Bushinsky DA, Charrow J, Desnick RJ, et al. Sustained, long-term renal stabilization after 54\u00a0months of agalsidase beta therapy in patients with Fabry disease. J Am Soc Nephrol. 2007;18:1547\u201357.","journal-title":"J Am Soc Nephrol"},{"key":"382_CR17","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1055\/s-0032-1313059","volume":"184","author":"B Petritsch","year":"2012","unstructured":"Petritsch B, K\u00f6stler H, Machann W, Horn M, Weng A, Goltz J, et al. Non-invasive Determination of Myocardial Lipid Content in Fabry Disease by 1H-MR Spectroscopy. Fortschr R\u00f6ntgenstr. 2012;184:1020\u20135.","journal-title":"Fortschr R\u00f6ntgenstr"},{"key":"382_CR18","first-page":"141","volume":"15","author":"JA Laser","year":"1985","unstructured":"Laser JA, Fowles RE, Mason JW. Endomyocardial biopsy. Cardiovasc Clin. 1985;15:141\u201363.","journal-title":"Cardiovasc Clin"},{"key":"382_CR19","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1161\/CIRCULATIONAHA.109.924167","volume":"122","author":"A Yilmaz","year":"2010","unstructured":"Yilmaz A, Kindermann I, Kindermann M, Mahfoud F, Ukena C, Athanasiadis A, et al. Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance. Circulation. 2010;122:900\u20139.","journal-title":"Circulation"},{"key":"382_CR20","doi-asserted-by":"publisher","first-page":"E935","DOI":"10.1152\/ajpendo.00095.2005","volume":"289","author":"JS Reingold","year":"2005","unstructured":"Reingold JS, McGavock JM, Kaka S, Tillery T, Victor RG, Szczepaniak LS. Determination of triglyceride in the human myocardium by magnetic resonance spectroscopy: reproducibility and sensitivity of the method. Am J Physiol Endocrinol Metab. 2005;289:E935\u20139.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"382_CR21","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/mrm.22734","volume":"65","author":"RD O\u2019Connor","year":"2011","unstructured":"O\u2019Connor RD, Xu J, Ewald GA, Ackerman JJH, Peterson LR, Gropler RJ, et al. Intramyocardial triglyceride quantification by magnetic resonance spectroscopy: In vivo and ex vivo correlation in human subjects. Magn Reson Med. 2011;65:1234\u20138.","journal-title":"Magn Reson Med"},{"key":"382_CR22","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/mrm.1910320205","volume":"32","author":"JA Hollander den","year":"1994","unstructured":"den Hollander JA, Evanochko WT, Pohost GM. Observation of cardiac lipids in humans by localized 1H magnetic resonance spectroscopic imaging. Magn Reson Med. 1994;32:175\u201380.","journal-title":"Magn Reson Med"},{"key":"382_CR23","volume-title":"Principles of Nuclear Magnetism","author":"A Abgragam","year":"1961","unstructured":"Abgragam A. Principles of Nuclear Magnetism. Oxford: Clarendon; 1961."},{"key":"382_CR24","volume-title":"Magnetic resonance imaging: theory and practice","author":"MT Vlaardingerbroek","year":"2003","unstructured":"Vlaardingerbroek MT. Magnetic resonance imaging: theory and practice. 3rd ed. Berlin, Heidelberg, NewYork: Springer; 2003.","edition":"3"},{"key":"382_CR25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1148\/radiol.2451061904","volume":"245","author":"RW Meer van der","year":"2007","unstructured":"van der Meer RW, Doornbos J, Kozerke S, Sch\u00e4r M, Bax JJ, Hammer S, et al. Metabolic imaging of myocardial triglyceride content: reproducibility of 1H MR spectroscopy with respiratory navigator gating in volunteers. Radiology. 2007;245:251\u20137.","journal-title":"Radiology"},{"key":"382_CR26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1148\/radiology.218.1.r01ja50215","volume":"218","author":"OP Simonetti","year":"2001","unstructured":"Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 2001;218:215\u201323.","journal-title":"Radiology"},{"key":"382_CR27","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/mrm.10372","volume":"49","author":"LS Szczepaniak","year":"2003","unstructured":"Szczepaniak LS, Dobbins RL, Metzger GJ, Sartoni-D\u2019Ambrosia G, Arbique D, Vongpatanasin W, et al. Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn Reson Med. 2003;49:417\u201323.","journal-title":"Magn Reson Med"},{"key":"382_CR28","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1194\/jlr.D700024-JLR200","volume":"49","author":"K Strobel","year":"2008","unstructured":"Strobel K, van den Hoff J, Pietzsch J. Localized proton magnetic resonance spectroscopy of lipids in adipose tissue at high spatial resolution in mice in vivo. J Lipid Res. 2008;49:473\u201380.","journal-title":"J Lipid Res"},{"key":"382_CR29","doi-asserted-by":"publisher","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","volume":"138","author":"RJ Desnick","year":"2003","unstructured":"Desnick RJ, Brady R, Barranger J, Collins AJ, Germain DP, Goldman M, et al. Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med. 2003;138:338\u201346.","journal-title":"Ann Intern Med"},{"key":"382_CR30","first-page":"1037","volume":"183","author":"W Wuest","year":"2011","unstructured":"Wuest W, Machann W, Breunig F, Weidemann F, Koestler H, Hahn D, et al. Right ventricular involvement in patients with Fabry\u2019s disease and the effect of enzyme replacement therapy. R\u00f6fo. 2011;183:1037\u201342.","journal-title":"R\u00f6fo"},{"key":"382_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.mric.2014.09.010","volume":"23","author":"MB Bizino","year":"2015","unstructured":"Bizino MB, Sala ML, de Heer P, van der Tol P, Smit JWA, Webb AG, et al. MR of multi-organ involvement in the metabolic syndrome. Magn Reson Imaging Clin N Am. 2015;23:41\u201358.","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"382_CR32","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1136\/heartjnl-2012-302546","volume":"100","author":"MB Bizino","year":"2014","unstructured":"Bizino MB, Hammer S, Lamb HJ. Metabolic imaging of the human heart: clinical application of magnetic resonance spectroscopy. Heart. 2014;100:881\u201390.","journal-title":"Heart"},{"key":"382_CR33","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1161\/CIRCULATIONAHA.110.955542","volume":"122","author":"ACT Ng","year":"2010","unstructured":"Ng ACT, Delgado V, Bertini M, van der Meer RW, Rijzewijk LJ, Hooi Ewe S, et al. Myocardial steatosis and biventricular strain and strain rate imaging in patients with type 2 diabetes mellitus. Circulation. 2010;122:2538\u201344.","journal-title":"Circulation"},{"key":"382_CR34","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/j.jacc.2008.07.062","volume":"52","author":"LJ Rijzewijk","year":"2008","unstructured":"Rijzewijk LJ, van der Meer RW, Smit JWA, Diamant M, Bax JJ, Hammer S, et al. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol. 2008;52:1793\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"382_CR35","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1093\/eurheartj\/ehn207","volume":"29","author":"RW Meer van der","year":"2008","unstructured":"van der Meer RW, Rijzewijk LJ, Diamant M, Hammer S, Sch\u00e4r M, Bax JJ, et al. The ageing male heart: myocardial triglyceride content as independent predictor of diastolic function. Eur Heart J. 2008;29:1516\u201322.","journal-title":"Eur Heart J"},{"key":"382_CR36","doi-asserted-by":"publisher","first-page":"517","DOI":"10.7326\/0003-4819-144-7-200604040-00011","volume":"144","author":"JM McGavock","year":"2006","unstructured":"McGavock JM, Victor RG, Unger RH, Szczepaniak LS, American College of Physicians, The American Physiological Society. Adiposity of the heart, revisited. Ann Intern Med. 2006;144:517\u201324.","journal-title":"Ann Intern Med"},{"key":"382_CR37","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1161\/CIRCULATIONAHA.106.645614","volume":"116","author":"JM McGavock","year":"2007","unstructured":"McGavock JM, Lingvay I, Zib I, Tillery T, Salas N, Unger R, et al. Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation. 2007;116:1170\u20135.","journal-title":"Circulation"},{"key":"382_CR38","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1177\/147323001204000430","volume":"40","author":"J Wu","year":"2012","unstructured":"Wu J, Yang L, Yang J, Yang CH, Zhang XH. Gender-specific normal levels of myocardial metabolites determined by localized 1H-magnetic resonance spectroscopy. J Int Med Res. 2012;40:1507\u201312.","journal-title":"J Int Med Res"},{"key":"382_CR39","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/jmri.21577","volume":"28","author":"B Madhu","year":"2008","unstructured":"Madhu B, Robinson SP, Howe FA, Griffiths JR. Effect of Gd-DTPA-BMA on choline signals of HT29 tumors detected by in vivo 1H MRS. J Magn Reson Imaging. 2008;28:1201\u20138.","journal-title":"J Magn Reson Imaging"},{"key":"382_CR40","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/01.rli.0000167125.79212.5d","volume":"40","author":"BN Joe","year":"2005","unstructured":"Joe BN, Chen VY, Salibi N, Fuangtharntip P, Hildebolt CF, Bae KT. Evaluation of 1H-magnetic resonance spectroscopy of breast cancer pre- and postgadolinium administration. Invest Radiol. 2005;40:405\u201311.","journal-title":"Invest Radiol"},{"key":"382_CR41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/nbm.1714","volume":"25","author":"PAT Baltzer","year":"2012","unstructured":"Baltzer PAT, Gussew A, Dietzel M, Rzanny R, Gajda M, Camara O, et al. Effect of contrast agent on the results of in vivo 1H MRS of breast tumors - is it clinically significant? NMR Biomed. 2012;25:67\u201374.","journal-title":"NMR Biomed"},{"key":"382_CR42","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/mrm.21937","volume":"61","author":"RE Lenkinski","year":"2009","unstructured":"Lenkinski RE, Wang X, Elian M, Goldberg SN. Interaction of gadolinium-based MR contrast agents with choline: implications for MR spectroscopy (MRS) of the breast. Magn Reson Med. 2009;61:1286\u201392.","journal-title":"Magn Reson Med"},{"key":"382_CR43","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/S0730-725X(98)00143-X","volume":"16","author":"PE Sijens","year":"1998","unstructured":"Sijens PE, Oudkerk M, van Dijk P, Levendag PC, Vecht CJ. 1H MR spectroscopy monitoring of changes in choline peak area and line shape after Gd-contrast administration. Magn Reson Imaging. 1998;16:1273\u201380.","journal-title":"Magn Reson Imaging"},{"key":"382_CR44","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/mrm.23011","volume":"66","author":"B Rial","year":"2011","unstructured":"Rial B, Robson MD, Neubauer S, Schneider JE. Rapid quantification of myocardial lipid content in humans using single breath-hold 1H MRS at 3 Tesla. Magn Reson Med. 2011;66:619\u201324.","journal-title":"Magn Reson Med"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-016-0382-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-016-0382-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-016-0382-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T14:26:14Z","timestamp":1487687174000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-016-0382-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,28]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["382"],"URL":"https:\/\/doi.org\/10.1186\/s12872-016-0382-4","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,28]]},"article-number":"205"}}